Iron protein succinylate
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Iron protein succinylate
- DrugBank Accession Number
- DB11209
- Background
Not Available
- Type
- Small Molecule
- Groups
- Approved, Investigational
- Synonyms
- Not Available
- External IDs
- ITF 282
- ITF282
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Treatment of Anemia of pregnancy •••••••••••• •••••••• Treatment of Blood loss anemia •••••••••••• •••••••• Prevention of Iron deficiency •••••••••••• •••••• Treatment of Iron deficiency •••••••••••• •••••• Prevention of Iron deficiency anemia (ida) •••••••••••• •••••• - Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image FERPLEX FOL 40 MG + 0.185 MG/15 ML ORAL ÇÖZELTİ, 10 ADET Iron protein succinylate (40 mg) + Leucovorin calcium pentahydrate (0.185 mg) Solution Oral ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 2003-11-12 Not applicable Turkey KOMFER FOL 40 MG/185 MCG ORAL COZELTI, 10 FLK. Iron protein succinylate (800 mg) + Leucovorin calcium pentahydrate (0.235 mg) Solution Oral KOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. 2009-01-28 Not applicable Turkey KOMFER FOL 40 MG/185 MCG ORAL COZELTI, 20 FLK. Iron protein succinylate (800 mg) + Leucovorin calcium pentahydrate (0.235 mg) Solution Oral KOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. 2009-01-28 Not applicable Turkey - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image OLIGOFER 40 MG ORAL COZELTI 10 FLAKON Iron protein succinylate (40 mg) Solution Oral ITF İLAÇ SAN. VE TİC. LTD. ŞTİ. 2013-01-29 Not applicable Turkey PR Natal 400 Iron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (30 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (374 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1) Kit Oral PruGen, Inc Pharmaceuticals 2010-01-01 Not applicable US PR Natal 400 ec Iron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (3 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (400 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1) Kit Oral PruGen, Inc Pharmaceuticals 2010-01-01 Not applicable US PR Natal 430 Iron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (30 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (430 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1) Kit Oral PruGen, Inc Pharmaceuticals 2010-01-01 Not applicable US PR Natal 430 ec Iron protein succinylate (7.25 mg/1) + Ascorbic acid (120 mg/1) + Beta carotene (3000 [iU]/1) + Calcium carbonate (200 mg/1) + Cholecalciferol (400 [iU]/1) + Cupric oxide (2 mg/1) + Cyanocobalamin (.012 mg/1) + DL-alpha tocopheryl acetate (3 mg/1) + Ferrous bisglycinate hydrochloride (21.75 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (25 mg/1) + Nicotinamide (20 mg/1) + Omega-3 fatty acids (430 mg/1) + Pyridoxine hydrochloride (25 mg/1) + Riboflavin (4 mg/1) + Thiamine mononitrate (1.8 mg/1) + Zinc oxide (25 mg/1) Kit Oral PruGen, Inc Pharmaceuticals 2010-01-01 Not applicable US
Categories
- ATC Codes
- B03AB09 — Ferric proteinsuccinylate
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- VBJ9L90P4L
- CAS number
- 250705-13-6
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Unknown Status Treatment Chronic Heart Failure (CHF) / Iron Deficiency (ID) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution Oral 40 mg/15ml Granule, for solution Oral Solution Oral 60 mg Solution Oral Solution Oral Tablet Oral Solution Oral 40 mg Solution Oral 60 mg/22.5ml Granule Oral Kit Oral Capsule Oral Capsule; kit; tablet, film coated Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at December 03, 2015 16:51 / Updated at June 12, 2020 16:53